Nilsine Partners’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12M Buy
231,195
+1,489
+0.6% +$76.8K 0.83% 24
2026
Q2
$11.9M Buy
229,706
+8,084
+4% +$387K 0.83% 26
2026
Q1
$10.3M Buy
221,622
+166,311
+301% +$7.17M 0.8% 25
2025
Q4
$2.22M Buy
55,311
+3,290
+6% +$130K 0.19% 121
2025
Q3
$2.05M Sell
52,021
-1,661
-3% -$61.3K 0.18% 122
2025
Q2
$2M Buy
+53,682
New +$1.82M 0.2% 119

Other funds holding CPAI

Nilsine Partners's CPAI Position: Q3 2026 in Review

Nilsine Partners increased its Counterpoint Quantitative Equity ETF (CPAI) stake by 0.65% in Q3 2026, buying an estimated $76.8K and bringing the position to 231,195 shares worth $12M. The position accounts for 0.83% of the portfolio, ranked #24.

Nilsine Partners first reported a position in CPAI in Q2 2025 and has held it in 6 quarters since. 33 funds tracked by Wall St. Rank hold CPAI as of Q3 2026.

  • Nilsine Partners held 231,195 shares of Counterpoint Quantitative Equity ETF worth $12M as of Q3 2026.
  • Nilsine Partners bought 1,489 Counterpoint Quantitative Equity ETF shares in Q3 2026, an estimated $76.8K.
  • Counterpoint Quantitative Equity ETF made up 0.83% of Nilsine Partners's portfolio in Q3 2026, its #24 holding.
  • Nilsine Partners first reported a position in Counterpoint Quantitative Equity ETF in Q2 2025 and has held it in 6 quarters since.
  • 33 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q3 2026.

Based on Nilsine Partners's 13F filing for Q3 2026, filed 2 Nov 2026.